KRT13 and neoplasm: Tumor features were assessed by the evaluation of spheroid’s growth and proliferative ability in vitro, and the expression of E-Cadherin, a negative marker of the Epithelial to Mesenchymal Transition (EMT) [36], KRT13, and the differentiation marker Keratin 10 (KRT10).